— Know what they know.
Not Investment Advice
Also trades as: ONCS (NASDAQ) · $vol 1M

ONCSQ OTC

OncoSec Medical Incorporated
1W: +0.0% 1M: +0.0% 3M: +900.0% YTD: -90.0% 1Y: -90.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $60 mcap · 4M float · 2.69% daily turnover

Balance Sheet Trends

Total Assets
$22M -61.1% ▼
5Y CAGR: +7.5%
Total Liabilities
$16M -13.4% ▼
5Y CAGR: +28.3%
Shareholders Equity
$6M -83.9% ▼
5Y CAGR: -10.6%
Cash & Investments
$12M -73.2% ▼
5Y CAGR: +1.5%
Total Debt
$6M -15.6% ▼
Net Debt
-$6M +84.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$4M$25M$20M$46M$12M
Short-Term Investments$23M$0$0$0$0
Cash & ST Investments$27M$25M$20M$46M$12M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$29M$29M$23M$49M$15M
Property, Plant & Equip.$1M$1M$7M$6M$6M
Goodwill & Intangibles$0$0$0$448K$379K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$359K$354K$319K$274K$623K
Total Non-Current Assets$2M$1M$7M$7M$7M
Total Assets$30M$30M$30M$56M$22M
— Liabilities —
Accounts Payable$0$2M$0$0$0
Short-Term Debt$0$84K$970K$1M$937K
Deferred Revenue$0-$2M-$5M$0-$3M
Other Current Liabilities$978K$2M$13M$0$3M
Total Current Liabilities$6M$5M$10M$8M$7M
Long-Term Debt$0$0$481K$0$0
Other Non-Current Liab.$1M$636K$0$5M$5M
Total Non-Current Liabilities$1M$636K$6M$10M$9M
Total Liabilities$7M$6M$16M$18M$16M
— Equity —
Common Stock$5K$1K$2K$4K$4K
Retained Earnings-$134M-$164M-$207M-$252M-$286M
Accumulated OCI-$16K$169K-$20K-$79K$247K
Total Stockholders Equity$23M$24M$14M$38M$6M
Total Liabilities & Equity$30M$30M$30M$56M$22M
— Key Metrics —
Total Debt$0$84K$8M$7M$6M
Net Debt-$4M-$25M-$13M-$39M-$6M
Total Investments$23M$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms